P704 Do antiglycan antibodies have an impact on the course of Crohn's disease? (original) (raw)

Profile image of Bulent BabanBulent Baban

2013, Journal of Crohn's and Colitis

visibility

description

1 page

link

1 file

Evaluation of inflammatory activity in Crohn’s disease and ulcerative colitis

Maria de Lourdes Abreu Ferrari

World Journal of Gastroenterology, 2012

View PDFchevron_right

Crohn’s disease in women

Ivana Plavsic

International Journal of Women's Health, 2013

View PDFchevron_right

Combination of genetic and quantitative serological immune markers are associated with complicated Crohnʼs disease behavior

Emil Chuang

Inflammatory Bowel Diseases, 2011

View PDFchevron_right

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn’s disease after failure of two other anti-TNF antibodies

P. Michetti

Alimentary Pharmacology & Therapeutics, 2010

View PDFchevron_right

The Association of Crohn’s Disease, Celiac Disease and Selective Ig A Deficiency

Vanya Gerova

International Journal of Celiac Disease, 2016

View PDFchevron_right

Serum protein profile of Crohn's disease treated with infliximab

Gerassimos Mantzaris

Journal of Crohn's and Colitis, 2013

View PDFchevron_right

Behaviour of Crohn's disease according to the Vienna classification

David Sachar

Gut, 2002

View PDFchevron_right

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Gökhan Kabaçam

The Turkish Journal of Gastroenterology, 2010

View PDFchevron_right

An investigation of Crohn's Disease in the Oral Cavity

Maison Ramadan Elchames

2016

View PDFchevron_right

Diagnosis and assessment of Crohns disease: The present and the future

Giovanni Terrosu

Expert Review of Gastroenterology and Hepatology, 2010

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Arthritis or vasculitis as presenting symptoms of Crohn’s disease

Ori Segol

Rheumatology International, 2005

View PDFchevron_right

Celiac disease as an autoimmune condition

Genel Sur

Central European Journal of Immunology, 2014

View PDFchevron_right

An Introduction to Genetics and Application to Crohnʼs Disease

Ginger Salvadalena

Journal of Wound, Ostomy and Continence Nursing, 2007

View PDFchevron_right

Continuing low incidence of Crohn’s disease in Northwest Greece

Ioannis Dimoliatis

Digestive and Liver Disease, 2003

View PDFchevron_right

Autoimmune diseases in the TH17 era

Luis Fernando Carrillo Andrade

Brazilian Journal of Medical and Biological Research, 2009

View PDFchevron_right

Functional Modulation of Crohn’s Disease Myofibroblasts by Anti-Tumor Necrosis Factor Antibodies

David Rampton

Gastroenterology, 2007

View PDFchevron_right

Inflammatory Bowel Disease. From Bench to Bedside

Fergus Shanahan

Digestive and Liver Disease, 2004

View PDFchevron_right

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

N. Mortensen

Gut, 2006

View PDFchevron_right

Immune Response and Gene Polymorphism Profiles in Crohnʼs Disease and Ulcerative Colitis

Ivan Saraiva

Inflammatory Bowel Diseases, 2009

View PDFchevron_right

CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract

Victor Reyes

World Journal of Gastroenterology, 2009

View PDFchevron_right

Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis

James Richter

Annals of Internal Medicine, 2012

View PDFchevron_right

Anti‐actin IgA antibodies in severe coeliac disease

Alessandro Granito

2004

View PDFchevron_right

Addition of an immunomodulator as a rescue therapy for loss of response to adalimumab dose escalation in patients with Crohn's disease

Gerassimos Mantzaris

Journal of Crohn's & colitis, 2015

View PDFchevron_right

Rheumatologic Manifestations of Gastrointestinal Diseases

Sterling West

Gastroenterology Clinics of North America, 1998

View PDFchevron_right

Colorectal Cancer and Inflammatory Bowel Disease

Vlad Padureanu

Colorectal Cancer - From Pathogenesis to Treatment, 2016

View PDFchevron_right

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease

guy lambrecht

Clinical Gastroenterology and Hepatology, 2020

View PDFchevron_right

Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations

J.enrique Domínguez-muñoz

European journal of …, 2007

View PDFchevron_right

Prevention of Post-operative Recurrence in Crohn's Disease

Kim Jong

Intestinal Research, 2008

View PDFchevron_right

Treatment of autoimmune disease with monoclonal anti-CD4 antibodies

Matthew Waldor

Immunology series, 1989

View PDFchevron_right

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Philippe Van Hootegem

The Lancet, 2008

View PDFchevron_right

Correlation of Circulating Cathelcidin Level and Inflammatory Bowel Disease Activity

SAMIR ELBAZ

Journal of the Egyptian Society of Parasitology

View PDFchevron_right

Autoimmune diseases - New insights into a troublesome field

Martin Risch

Journal of Translational Autoimmunity, 2021

View PDFchevron_right

Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future

Saurabh dawra

Future pharmacology, 2024

View PDFchevron_right

Biologic Therapies for Inflammatory Bowel Diseases

Vassilis Valatas

2013

View PDFchevron_right

Autoimmune Gastritis and Hypochlorhydria: Known Concepts from a New Perspective

marica vavallo

International journal of molecular sciences, 2024

View PDFchevron_right

MedicineClinical Sciences